Home

RICHARD GAYNOR

CIK 1741284 · President of R&D · last filed 2026-07-06

RICHARD GAYNOR is a President of R&D who has filed 37 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing shows the insider bought $33.1K of ZLAB on Jul 6, 2026. Across all open-market trades the lifetime net is −$156.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.49M

Companies

4

Total Filings

37

Lifetime Open-Market Net

-$156.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZLAB Director 80,737 $20.88 $1.69M -$70.6K 9 2026-07-06
ALKS Director 37,226 $48.37 $1.80M $0 16 2026-05-22
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Director — $0.04 — $0 3 2022-06-16
Neon Therapeutics, Inc. (NTGN) Delisted President of R&D 0 — — -$85.4K 7 2020-05-06

Recent Filings

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-06 ZLAB Buy (P) +1,736 $33.1K EDGAR
2026-06-22 ZLAB Grant (A) +22,371 $0 EDGAR
2026-05-22 ALKS Grant (A) — $0 EDGAR
2026-05-22 ALKS Mixed +4,667 -$54.5K EDGAR
2026-03-19 ZLAB Buy (P) +1,731 $32.7K EDGAR
2025-06-23 ZLAB Grant (A) +10,831 $0 EDGAR
2025-06-02 ALKS Mixed +6,089 -$58.9K EDGAR
2025-05-23 ALKS Grant (A) — $0 EDGAR
2025-03-06 ZLAB Sell (S) −2,500 -$87.7K EDGAR
2025-03-05 — Notice (144) −2,500 -$87.7K EDGAR
Showing 1–10 of 37
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.